Two Phase III trials found that apixaban was more effective for stroke prevention than either aspirin or warfarin in patients with atrial fibrillation (AF), with a similar (versus aspirin ...

Based on this trial, apixaban was superior to aspirin in patients unsuitable for warfarin in stroke prevention in nonvalvular AF. In the ARISTOTLE trial, apixaban was compared with warfarin for ...

There are anticoagulants such as warfarin, heparin, and new oral medications like rivaroxaban and apixaban. These have been widely applied in patients with atrial fibrillation, a clinical ...

All other potential causes were excluded. Cessation of warfarin therapy and conversion to apixaban with close monitoring alleviated the hair loss. Warfarin therapy is a rare cause of alopecia but ...

Apixaban was the most utilized antithrombotic in both groups (41% in CKD and 40% in ESRD) followed by warfarin in the ESRD group (24%) and aspirin monotherapy (20%) in the CKD group. Among those on ...

The secondary outcomes were 30-day blood transfusion requirement and new thromboembolic event. Results Apixaban was associated with lower PPB risk than warfarin (adjusted HR (aHR) 0.39, 95% CI 0.24 to ...

Stopping blood thinners before or during surgery for a CIED may result in little to no difference in undesirable outcomes such as blood clots or bleeding events when compared to taking them ...

apixaban, dalteparin, enoxaparin, dabigatran, edoxaban, rivaroxaban) or 7 days (warfarin, heparin, low molecular weight heparin). 7 Taken as a preventive measure against blood clots in the legs ...

Non-adherent persistence was highest with apixaban (29.0%) and lowest with dabigatran (19. ... differential impact of varying prescription gaps on persistence), possibly due to patients on warfarin ...

Apixaban was chosen for its established evidence and safety profile for stroke prophylaxis in non-valvular atrial fibrillation compared with other direct oral anticoagulants or warfarin.3 An ...

Light spotting after menopause can be caused by a few different things, including non-cancerous polyps, vaginal dryness, or excess growth of the tissue that lines the uterus. Less common causes range ...